AT391480B - Verfahren zur herstellung des enzymes myeloperoxydase - Google Patents
Verfahren zur herstellung des enzymes myeloperoxydase Download PDFInfo
- Publication number
- AT391480B AT391480B AT48089A AT48089A AT391480B AT 391480 B AT391480 B AT 391480B AT 48089 A AT48089 A AT 48089A AT 48089 A AT48089 A AT 48089A AT 391480 B AT391480 B AT 391480B
- Authority
- AT
- Austria
- Prior art keywords
- enzyme
- purification
- senday
- myeloperoxidase
- activation
- Prior art date
Links
- 102000004190 Enzymes Human genes 0.000 title claims description 21
- 108090000790 Enzymes Proteins 0.000 title claims description 21
- 238000004519 manufacturing process Methods 0.000 title claims description 8
- 102000003896 Myeloperoxidases Human genes 0.000 claims description 13
- 108090000235 Myeloperoxidases Proteins 0.000 claims description 13
- 210000000265 leukocyte Anatomy 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 9
- 230000004913 activation Effects 0.000 claims description 8
- 238000000746 purification Methods 0.000 claims description 8
- 241000700605 Viruses Species 0.000 claims description 5
- 102000014150 Interferons Human genes 0.000 claims description 4
- 108010050904 Interferons Proteins 0.000 claims description 4
- 230000003213 activating effect Effects 0.000 claims description 4
- HIYAVKIYRIFSCZ-CVXKHCKVSA-N Calcimycin Chemical compound CC([C@H]1OC2([C@@H](C[C@H]1C)C)O[C@H]([C@H](CC2)C)CC=1OC2=CC=C(C(=C2N=1)C(O)=O)NC)C(=O)C1=CC=CN1 HIYAVKIYRIFSCZ-CVXKHCKVSA-N 0.000 claims description 3
- 108010062580 Concanavalin A Proteins 0.000 claims description 3
- 108090001090 Lectins Proteins 0.000 claims description 3
- 102000004856 Lectins Human genes 0.000 claims description 3
- 241000219739 Lens Species 0.000 claims description 3
- 240000004322 Lens culinaris Species 0.000 claims description 3
- 235000010666 Lens esculenta Nutrition 0.000 claims description 3
- HIYAVKIYRIFSCZ-UHFFFAOYSA-N calcium ionophore A23187 Natural products N=1C2=C(C(O)=O)C(NC)=CC=C2OC=1CC(C(CC1)C)OC1(C(CC1C)C)OC1C(C)C(=O)C1=CC=CN1 HIYAVKIYRIFSCZ-UHFFFAOYSA-N 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 229940079322 interferon Drugs 0.000 claims description 3
- 239000002523 lectin Substances 0.000 claims description 3
- 108010047620 Phytohemagglutinins Proteins 0.000 claims description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 2
- 238000011097 chromatography purification Methods 0.000 claims description 2
- 239000005289 controlled pore glass Substances 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 230000001885 phytohemagglutinin Effects 0.000 claims description 2
- 239000007858 starting material Substances 0.000 claims description 2
- 239000002555 ionophore Substances 0.000 claims 1
- 230000000236 ionophoric effect Effects 0.000 claims 1
- 239000000243 solution Substances 0.000 description 13
- 210000004027 cell Anatomy 0.000 description 10
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000000725 suspension Substances 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 235000019270 ammonium chloride Nutrition 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 229920000936 Agarose Polymers 0.000 description 2
- 206010061216 Infarction Diseases 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 230000007574 infarction Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000001508 potassium citrate Substances 0.000 description 2
- 229960002635 potassium citrate Drugs 0.000 description 2
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 2
- 235000011082 potassium citrates Nutrition 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 229910000608 Fe(NO3)3.9H2O Inorganic materials 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000711408 Murine respirovirus Species 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 239000003710 calcium ionophore Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- CJAONIOAQZUHPN-KKLWWLSJSA-N ethyl 12-[[2-[(2r,3r)-3-[2-[(12-ethoxy-12-oxododecyl)-methylamino]-2-oxoethoxy]butan-2-yl]oxyacetyl]-methylamino]dodecanoate Chemical compound CCOC(=O)CCCCCCCCCCCN(C)C(=O)CO[C@H](C)[C@@H](C)OCC(=O)N(C)CCCCCCCCCCCC(=O)OCC CJAONIOAQZUHPN-KKLWWLSJSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 108010074605 gamma-Globulins Proteins 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000012510 hollow fiber Substances 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 229940047124 interferons Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- BUKHSQBUKZIMLB-UHFFFAOYSA-L potassium;sodium;dichloride Chemical compound [Na+].[Cl-].[Cl-].[K+] BUKHSQBUKZIMLB-UHFFFAOYSA-L 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0065—Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
- C12Q1/28—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving peroxidase
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU105188A HU204081B (en) | 1988-03-04 | 1988-03-04 | Process for producing myeloperoxidase enzyme |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ATA48089A ATA48089A (de) | 1990-04-15 |
| AT391480B true AT391480B (de) | 1990-10-10 |
Family
ID=10952641
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT48089A AT391480B (de) | 1988-03-04 | 1989-03-03 | Verfahren zur herstellung des enzymes myeloperoxydase |
Country Status (4)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112012025339A2 (pt) | 2010-04-14 | 2019-09-24 | Hoffmann La Roche | ''método para a obtenção de um polipeptídeo na forma monomérica ou na forma agregrada, método para a produção de um polipetídeo, uso e kit'' |
-
1988
- 1988-03-04 HU HU105188A patent/HU204081B/hu not_active IP Right Cessation
-
1989
- 1989-03-03 JP JP5021189A patent/JPH0663B2/ja not_active Expired - Lifetime
- 1989-03-03 AT AT48089A patent/AT391480B/de not_active IP Right Cessation
- 1989-03-06 DE DE19893907162 patent/DE3907162A1/de active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPH01269491A (ja) | 1989-10-26 |
| JPH0663B2 (ja) | 1994-01-05 |
| HUT50210A (en) | 1989-12-28 |
| DE3907162C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1992-05-21 |
| DE3907162A1 (de) | 1989-09-14 |
| HU204081B (en) | 1991-11-28 |
| ATA48089A (de) | 1990-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69432859T2 (de) | Verfahren zur reinigung von kollagenase | |
| AT407115B (de) | Verfahren zur herstellung eines konzentrates von standardisiertem, menschlichem von willebrand-faktor | |
| DE69017050T2 (de) | Verfahren zur isolierung von faktor viii. | |
| FR2461500A1 (fr) | Procede de production d'une substance capable de stimuler la proliferation et la differenciation des cellules souches granulopoietiques humaines | |
| DE2734821A1 (de) | Verfahren zur herstellung einer blutgerinnungsfoerdernden praeparation aus menschlichem blutplasma | |
| DE3886175T2 (de) | Trigramin, ein Polypeptid, das die Aggregation der Blutplättchen hemmt. | |
| EP0409053B1 (de) | Verfahren zur Reinigung von Annexinen | |
| EP1074615A1 (de) | Verfahren zur Reindarstellung der den Blutgerinnungsfaktor VII aktivierenden Protease, ihres Proenzyms oder eines Gemisches beider Proteine mittels Affinitätschromatographie | |
| EP0246439B1 (de) | Steriles Plasmaaustauschmittel | |
| DE2440529C3 (de) | Hyaluronidase-Präparat aus menschlicher Plazenta | |
| DE2752694A1 (de) | Verfahren zur gewinnung von immunglobulin zur intravenoesen verabreichung | |
| EP0271885B1 (de) | Arzneimittel enthaltend das Gewebeprotein PP4, Verfahren zur Herstellung von PP4 und zu seiner Pasteurisierung sowie die Verwendung von PP4 | |
| EP0101063B1 (de) | Neues Polypeptid mit Wirkung auf das Immunsystem, Verfahren zu seiner Isolierung und Reinigung, seine Verwendung und dieses enthaltende Mittel | |
| DE2459915C3 (de) | Aktive Verbindung des Plasminogen- Typs, Verfahren zu ihrer Reinigung und ihre Verwendung | |
| EP0367840A1 (de) | Verfahren zur Herstellung eines hochreinen, nicht infektiösen Antihämophiliefaktors mittels Chromatographie | |
| DE1442134C3 (de) | In vivo antikoagulierend wirkendes und defibrinierendes Enzym | |
| AT391480B (de) | Verfahren zur herstellung des enzymes myeloperoxydase | |
| DE3586952T2 (de) | Fibrinophiler urokinase-komplex und dessen herstellung. | |
| EP0343275A1 (de) | Verfahren zur Herstellung eines hochreinen, virusfreien Antihämophiliefaktors mittels Chromatographie | |
| DE3034045C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| DE1617332C3 (de) | Verfahren zum Isolieren eines wasserlöslichen Protein-Metall-Chelats mit antiphlogistischer Wirkung | |
| DE3101001A1 (de) | Verfahren zur konzentration und reinigung des antihaemophilie-faktors oder faktor viii | |
| DE2715748B2 (de) | Gereinigte aktive Verbindung des Plasminogen-Typs menschlichen Ursprungs und ihre Verwendung | |
| DE2533183C3 (de) | Verfahren zum Herstellen gereinigter Immunglobuline | |
| AT392003B (de) | Verfahren zur herstellung eines insbesondere zur wundheilung oder zur behandlung in der geriatrie verwendbaren wirkstoffes aus saeugetierblut durch papainhydrolyse und ein einen solchen wirkstoff enthaltendes praeparat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |